Agios Pharmaceuticals, Inc.
AGIO· Nasdaq
AGIOAgios Pharmaceuticals, Inc.
Source filing unavailable
| Metric | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|
| Revenue | $33.90M | $6.27M | $6.27M |
| Net Income | $3.70M | -$11.18M | -$4.65M |
| EPS Diluted | $0.10 | -$0.52 | -$1.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR
